If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Noritaka Ariyoshi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Polychlorinated Biphenyls Medicine & Life Sciences
3,4,5,3',4'-pentachlorobiphenyl Medicine & Life Sciences
Liver Chemical Compounds
Rats Chemical Compounds
Cytochrome P-450 Enzyme System Medicine & Life Sciences
Cytochrome P-450 CYP3A Medicine & Life Sciences
Poisons Medicine & Life Sciences
Liver Microsomes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

A randomized controlled, open-label early phase II trial comparing incidence of FOLFIRI.3-induced diarrhoea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancer

Yamazaki, K., Ariyoshi, N., Miyauchi, H., Ohira, G., Kaneya, N., Yamamoto, K., Arai, K., Yamazaki, S., Matsubara, H., Suzuki, T. & Ishii, I., Jan 1 2019, (Accepted/In press) In : Journal of Clinical Pharmacy and Therapeutics.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Diarrhea
Incidence
Ursodeoxycholic Acid
Sodium Bicarbonate

Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro: a different effect on asunaprevir versus daclatasvir and beclabuvir

Matsumoto, J., San, S. N., Fujiyoshi, M., Kawauchi, A., Chiba, N., Tagai, R., Sanbe, R., Yanaka, S., Sakaue, H., Kato, Y., Nakamura, H., Yamada, H. & Ariyoshi, N., Jan 1 2019, (Accepted/In press) In : Journal of Human Genetics.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP3A
Antiviral Agents
8-cyclohexyl-N-((dimethylamino)sulfonyl)-1,1a,2,12b-tetrahydro-11-methoxy-1a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)cycloprop(d)indolo(2,1-a)(2)benzazepine-5-carboxamide
In Vitro Techniques
BMS-790052
2 Citations (Scopus)

Efficacy of 2.5-mg prasugrel in elderly or low-body-weight patients

Wakabayashi, S., Ariyoshi, N., Kitahara, H., Fujii, K., Fujimoto, Y. & Kobayashi, Y., Jan 1 2018, In : Circulation Journal. 82, 9, p. 2326-2331 6 p.

Research output: Contribution to journalArticle

clopidogrel
Body Weight
Blood Platelets
Percutaneous Coronary Intervention
Prasugrel Hydrochloride

High residual platelet reactivity after switching from clopidogrel to low-dose prasugrel in Japanese patients with end-stage renal disease on hemodialysis

Ohno, Y., Kitahara, H., Fujii, K., Kohno, Y., Ariyoshi, N., Nishi, T., Fujimoto, Y. & Kobayashi, Y., Jan 1 2018, (Accepted/In press) In : Journal of Cardiology.

Research output: Contribution to journalArticle

clopidogrel
Chronic Kidney Failure
Renal Dialysis
Blood Platelets
Therapeutics
1 Citation (Scopus)

Minor contribution of CYP3A5 to the metabolism of hepatitis C protease inhibitor paritaprevir in vitro

San, S. N., Matsumoto, J., Saito, Y., Koike, M., Sakaue, H., Kato, Y., Fujiyoshi, M., Ariyoshi, N. & Yamada, H., Jan 1 2018, (Accepted/In press) In : Xenobiotica.

Research output: Contribution to journalArticle

Cytochrome P-450 CYP3A
Hepatitis C
Protease Inhibitors
Metabolism
Liver Microsomes